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Abstract: Lens-induced glaucoma comprises a number of different glaucomatous processes 
occurring in the elderly that share in common the role of the crystalline lens in the mechanism 
of increase in intraocular pressure. We will review the anatomic predisposing factors, their 
physiology, signs and symptoms, and therapeutic approach. We will consider two studies and 
discuss the visual results and risk factors associated with these pathologic conditions.
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Introduction
Lens-induced glaucoma in the elderly can be subdivided into two major categories. 
The first category relates to a blockage of the anterior flow of the aqueous humor from 
the lens that results in an increase of intraocular pressure (IOP). Conditions included in 
this category are: (1) pupillary block glaucoma caused by an intumescent cataractous 
lens (phacomorphic glaucoma), (2) ectopia lentis. The second category is characterized 
by the blockage of the trabecular meshwork from lens proteins (phacolytic glaucoma), 
lens material or debris, and rarely by phacoanaphylactic response to lens material.
Pupillary block glaucoma
This type of glaucoma is characterized by the obstruction of the aqueous outflow 
by the apposition of the iris root to the trabecular meshwork. Eyes which develop 
angle-closure glaucoma secondary to pupillary block have been observed to have 
several predisposing anatomic factors. The most important factor is a shallow anterior 
chamber. The depth of the chamber is dependent on the dimensions of the lens, the 
cornea, and the axial length of the globe. With aging, the lens assumes greater thickness, 
a greater curve of its anterior surface, and the zonules loosen.1–4 These factors cause 
increasing shallowness of the anterior chamber and iridolenticular contact,5 which 
results in a greater amount of pupillary block.3 As a consequence, hyperopic eyes have 
a propensity for pupillary block.
The physiology of angle-closure glaucoma is as follows. There are two muscles 
in the iris: the sphincter and the dilator. During mid-dilation, the posterior component 
of the dilator’s force reaches a maximum.7–9 If this force becomes strong enough to 
overcome the anterior component of the dilator’s force, then the iris is pushed against 
the lens and a pupillary block will ensue. This will obstruct the aqueous flow from 
the posterior to the anterior chamber. The aqueous will accumulate in the posterior 
chamber, which pushes the iris forward and finally the iris root will come in contact Clinical Interventions in Aging 2009:4 332
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with the trabecular meshwork and lead to angle-closure 
glaucoma. This mechanism is facilitated by the anatomic 
predisposing factors that were mentioned previously.
A senile cataractous lens that has progressed enough to 
become intumescent, has an increased anteroposterior length, 
which could lead to pupillary block. This type of glaucoma 
is named phacomorphic (Figure 1).
Phacomorphic glaucoma often occurs from a mature 
cataract, but may also occur from spherophakia in 
Weill–Marchesani syndrome. Phacomorphic glaucoma 
could present asymptomatically as chronic angle-closure 
glaucoma, however it more often presents as acute angle-
closure glaucoma. Acute angle-closure glaucoma will cause a 
significant increase in IOP, which is characterized by ocular 
pain, headache, blurred vision, perception of halos around 
lights (due to the corneal edema), and also nausea, vomiting, 
bradycardia, and diaphoresis due to the vasovagal response. 
Symptoms usually occur at night because mid-dilation 
predisposes relative pupillary block.
The clinical examination reveals reduced visual 
acuity secondary to corneal edema, conjuctival injection, 
a mid-dilated pupil, and, in the case of phacomorphic 
glaucoma, an intumescent cataractous lens which pushes the 
iris forward and reduces the depth of the anterior chamber 
peripherally. The latter also shows cells and flare. The 
fellow eye shows the same anatomic predisposing factors 
and probably a cataract (phacomorphic).10
Treatment focuses on two objectives: lower the IOP as 
soon as possible and prevent the diseased and fellow eye 
from another episode.11
Initially, IOP-lowering medications are used. Topical beta 
blockers, carbonic anhydrase inhibitors, and hyperosmotic 
agents (mannitol IV) are the mainstay of medical treatment. 
Parasympathomimetic agents (pilocarpine 1% or 2%) tend 
to increase pupillary block, so they should be used with 
caution.12 When this approach fails to lower IOP, then 
some other methods can be recruited: corneal depression 
with a Zeiss 4-mirror lens, iridectomy with the Nd:YAG 
laser, gonioplasty with an argon laser, coreoplasty with 
an argon laser, and application of digital massage.11,13,14 
If the fellow eye is also anatomically predisposed to angle-
closure glaucoma, prophylactic laser iridotomy should be 
performed.
In the case of phacomorphic glaucoma, after IOP control 
and establishing intraocular inflammation, we proceed to 
cataract extraction, which erases the major causative factor 
of angle-closure glaucoma.
Ectopia lentis
This clinical entity may present as an isolated inherited form 
such as ectopia lentis and ectopia lentis et pupillae. Ectopia 
lentis may also be associated with systemic disorders such 
as Marfan’s syndrome, homocystinuria, Weill–Marchesani 
syndrome, hyperlysinemia, and sulfite oxidase deficiency. 
The biochemical defects in these conditions result in 
defective zonular apparatus and subluxation/dislocation of 
the lens often occurs (Figures 2, 3).
Dislocation of the crystalline lens may be secondary to 
trauma.15
Symptoms vary according to the individual state of the 
lens. Minimal subluxation may be asymptomatic. Progressive 
disruption of the zonules allows the lens to assume a more 
spherical shape, which results in increasing degrees of 
myopia. If the lens is shifted within the pupillary axis, then 
Figure 1 Hypermature cataractous lens. Figure 2 ectopia lentis.Clinical Interventions in Aging 2009:4 333
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monocular diplopia may ensue. The loss of zonular support 
results in difficulties with accommodation and near vision. 
Complete dislocation from the pupillary axis renders the 
patient hyperopic because of an aphakic optical condition. 
When dislocation results in pupillary block and angle-closure 
glaucoma is present, the patient experiences a red and painful 
eye, decreased visual acuity, and sometimes headache, 
nausea, and vomiting.
Signs include phacodonesis, iridodonesis, shallowing of 
the anterior chamber either symmetrically or asymmetrically, 
and a difference in the depth of the anterior chamber between 
the two eyes. Gonioscopically, the iris may be seen to assume 
the shape of a volcano with the pupil forming the central 
crater. This is the result of the anterior movement of the lens 
and increased contact with the middle third of the iris.
The therapeutic approach depends on the degree 
of dislocation and the symptoms. In cases of partial 
subluxation within the pupillary space that does not 
cause significant visual impairment or pupillary block 
glaucoma, a conservative nonintervention strategy could 
be followed. When the previous condition is accompanied 
by pupillary block, then a laser peripheral iridectomy 
is the appropriate solution. Total anterior dislocation 
requires removal of the lens. Dislocation in the vitreous 
cavity may be followed carefully as long as the cataract 
is not hypermature and no inflammation or glaucoma is 
noticed. If any of these factors are present, removal of 
the lens is indicated.
Ciliary block (malignant) glaucoma sometimes may 
be confused with phacomorphic glaucoma in cases where 
the anterior chamber is too shallow. However, malignant 
glaucoma in its classic form occurs after surgery for 
glaucoma and is characterized by the misdirection of aqueous 
fluid into the vitreous cavity.16–31
Phacolytic glaucoma
This acute open-angle glaucoma is the result of the leakage 
of lenticular material from senile hypermature or Morgagnian 
cataract through an intact lens capsule (Figure 4). The 
presentation is a red and painful eye, history of gradual decline 
of visual acuity reflecting the slow maturation of the cataract, 
corneal edema, high IOP, an open–angle in gonioscopy, 
a heavy flare, and aqueous cells larger than the lymphocytes 
seen in uveitis. These cells are thought to be macrophages 
swollen with eosinophilic lenticular material which they 
have engulfed.32 Soft white patches on the lens capsule can 
be observed, which are aggregates of macrophages trying to 
seal the site of leakage.33 The fellow eye usually has a mature 
cataract and a deep anterior chamber.
The original theory about the pathogenesis of this 
condition was that the macrophages were the major culprit 
of increase in IOP by blocking the trabecular meshwork.33,34 
Later research by Epstein and colleagues,35 Yanoff and 
Scheie,32 and Dueker36 emphasized the role of heavy 
molecular proteins (HMW) leaking from the lens in the 
obstruction of the aqueous outflow and de-emphasized the 
role of the macrophages. As a consequence, the examination 
of the anterior chamber fluid for the presence of HMW 
protein has become an important diagnostic aid in suspected 
and atypical cases of phacolytic glaucoma, but is not yet 
widely available.
The majority of patients with phacolytic glaucoma can be 
managed through topical cycloplegia, topical steroids, and 
Figure 3 Post-traumatic lens dislocation.
Figure 4 Lens proteins in the anterior chamber, phacolytic glaucoma.3Clinical Interventions in Aging 2009:4 334
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aqueous suppressants. If despite intensive antiglaucomatous 
therapy, IOP continues to increase, emergency admission 
may be advocated, and in rare instances urgent cataract or 
vitreoretinal surgery may be required.37–41
Lens-particle glaucoma
In contrast to phacolytic glaucoma, this form of lens-induced 
glaucoma is associated with a grossly disrupted capsule and 
the presence of obvious fragments of lens material in the 
anterior chamber. It may occur after cataract surgery, trauma 
to the lens, or Nd:YAG posterior capsulotomy. The IOP 
increase is due to the obstruction of the aqueous outflow by 
the lens particles.32 Despite the presence of macrophages as 
scavengers of the lens material, their role in the pathogenesis 
of the glaucoma is not significant.
Initially, a trial of medical antiglaucomatous therapy 
may be attempted, but miotics should be avoided. Mild to 
moderate steroid therapy can help to prevent synechiae, 
pupillary membranes, cystoid macular edema, etc. If the 
glaucoma is severe and/or there is a large amount of lens 
material in the anterior chamber, its surgical removal should 
be undertaken.
Phacoanaphylactic glaucoma
Phacoanaphylactic glaucoma is an inflammatory reaction 
directed against lenticular antigens with elevation of the 
IOP due to involvement of the trabecular meshwork by the 
inflammation or by obstruction from inflammatory cells. 
A less usual mechanism is the formation of synechiae 
resulting in pupillary block.
The series of events leading to the IOP rise is as follows: 
the patient is sensitized to his own lens antigens and these 
proteins are kept in an immunologically privileged site 
within the lens capsule. After an eye surgery or other trauma 
to the lens capsule, these lens antigens are exposed to the 
circulation, they may be recognized as ‘foreign’ by the 
individual’s immune system and they incite an inflammatory 
response. A matter not completely elucidated is why some 
patients develop this reaction and others do not.
The time interval between the trauma and the onset 
of inflammation is 24 hours to 14 days. The clinical signs 
include lid edema, chemosis, conjuctival injection, corneal 
edema, heavy anterior chamber reaction, posterior synechiae, 
and mutton fat keratic precipitates.
Pathologically, a granulomatous reaction is noted with 
polymorphonuclear, epithelioid, and giant cells surrounding 
lenticular material. Phacoanaphylaxis is not the correct name of 
this condition since it is not an allergy. Eosinophils may be found 
but not immunoglobulin E (IgE). The mechanism causing the 
reaction seems to be an Arthus-type immune complex reaction 
mediated by IgG and the complement system.42,43 In the past, 
the differentiation between phacoanaphylaxis and sympathetic 
ophthalmia was confusing, but once it is understood that the 
former involves only the anterior segment of the eye, the 
diagnosis is easy.44,45
The first step in therapy is the effort to control the IOP 
and inflammation medically. If this proves unsuccessful 
then the next phase is surgical removal of the remaining 
lens material.46
Epidemiology: prognostic factors
There are two studies from the Indian Journal of 
Ophthalmology that investigate lens-induced glaucomas, more 
specifically phacomorphic and phacolytic glaucomas.
The first study47 deals with the clinical modes of 
presentation, the postoperative visual results, and the risk 
factors that relate to the visual outcome of such cases. The 
percentage of phacomorphic glaucomas (52.7%) is slightly 
higher than phacolytic (47.3%) and the latter is more common 
with increasing age probably due to aggregation of high 
molecular weight proteins in the crystalline lens over time. 
After surgical management with extracapsular cataract 
extraction, 57% of phacomorphic and 61% of phacolytic 
cases had good visual acuity (6/12 or better) and 10.2% of 
phacomorphic and 13.6% of phacolytic cases had poor visual 
recovery (6/60 or less). The conclusion in this study was that 
there was no statistically significant difference between the 
two groups on the final postoperative visual recovery. When 
they investigated the risk factors they found a statistically 
marginally significant increased risk (p = 0.05) of females 
having these glaucomas. Also, males had a slightly higher 
risk of obtaining poor postoperative visual acuity (odds 
ratio [OR] = 2.2; 95% confidence interval [CI]: 0.88–5.66), 
but this statement has to be analyzed with caution, because 
the mean age of males was higher than the females and age 
may be a confounding factor. A significant risk of poor 
visual acuity was found when the duration between the onset 
of pain and surgery exceeded five days (OR = 3.1; 95% 
CI: 1.21–8.13). Marginally significant risk of poor visual 
outcome was observed in cases of age higher than 60 years 
when compared with younger patients. Finally, between 
the level of preoperative IOP and final visual acuity, no 
significant association was found (p = 0.07).
The second study48 dealt with the frequency and types 
of lens-induced glaucoma, the reasons for late presentation, 
and the outcome of current management. The percentage of Clinical Interventions in Aging 2009:4 335
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phacomorphic glaucomas was higher in this study (72%) than 
the phacolytic (28%). A similar result occurred in relation 
to gender since the ratio of females:males was 1.7:1. The 
comparison between the two studies is difficult when we 
look at the visual results because the groups are different. 
In the latter study, 38.6% achieved a visual acuity of 6/60 or 
better, 31.2% less than 6/60, and 30.2% less than 3/60. In the 
phacolytic group, 65.9% had a poor outcome compared with 
59.8% of the phacomorphic group. This poor outcome was 
associated in the latter group with a longer distance from the 
hospital, longer duration of pain, and higher IOP at presenta-
tion. In the phacolytic group, only the distance was found to 
influence negatively the visual outcome. In this series, the 
final visual outcome is worse than in other studies, probably 
because the majority of the patients reported later than ten 
days after the onset of pain.
In conclusion, lens-induced glaucoma comprises a 
number of different glaucomatous processes occurring in 
the elderly that share in common the role of the crystalline 
lens in the mechanism of increase in IOP. Early diagnosis 
and treatment of mature cataract is very important since 
delayed treatment of lens-induced glaucoma may result in 
poor visual outcome.
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